Barbara Newton
Fred Hutchinson Cancer Research Center
10 Papers
611 Citations
Barbara Newton is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Congenital cytomegalovirus infection & Transplantation. The author has an hindex of 10, co-authored 10 publications.
Chat about Author
Papers
Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow Transplantation: A Double-Blind Trial
TL;DR: Acyclovir, a new antiviral agent, was compared to a placebo in a randomized double-blind trial of treatment for culture-proven herpes simplex virus infection after marrow transplantation as discussed by the authors.
309
Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients
TL;DR: Acyclovir treatment significantly shortened the median duration of viral shedding, new lesion formation, and time to first decrease in pain, resolution of pain, 50% healing, and total healing.
120
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
Joel D. Meyers,Nancy Flournoy,Jean E. Sanders,Robert W. McGuffin,Barbara Newton,LD Fisher,Lawrence G. Lum,Frederick R. Appelbaum,Kristine Doney,Keith M. Sullivan,Rainer Storb,C. Dean Buckner,E. Donnall Thomas +12 more
TL;DR: It is suggested that interferon given after transplantation reduces the risk for subsequent relapse of leukemia, and the effect of longer administration and of administration in patients with other underlying diseases will require additional trials.
86
Acyclovir treatment of varicella-zoster virus infection in the compromised host.
TL;DR: It is indicated that acyclovir is safe and effective for the treatment of varicella-zoster virus infection in the severely immunocompromised host.
58
•Journal Article
The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.
Finn Bo Petersen,Raleigh A. Bowden,Thornquist M,Joel D. Meyers,Buckner Cd,George W. Counts,Nelson N,Barbara Newton,Keith M. Sullivan,McIver J +9 more
TL;DR: It is suggested that the administration of intravenous immunoglobulin may be a practical and effective method to decrease the incidence of septicemia following marrow transplantation.
54